Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on STANDARD LIFE PLC. We currently have 12 research reports from 2 professional analysts.
|01Dec16 03:39||RNS||Additional Listing|
|01Dec16 03:24||RNS||Total Voting Rights|
|28Nov16 11:12||RNS||Director/PDMR Shareholding|
|21Nov16 04:15||RNS||Director/PDMR Shareholding|
|14Nov16 07:00||RNS||Possible strategic combination involving HDFC Life|
|09Nov16 12:24||RNS||Director/PDMR Shareholding|
|03Nov16 02:46||RNS||Director/PDMR Shareholding|
Frequency of research reports
Research reports on
STANDARD LIFE PLC
STANDARD LIFE PLC
Panmure Morning Note 11-10-2016
10 Nov 16
Last night Group FD Luke Savage came into our offices to hold a Q&A session with our sales team. It proved to be a very open, enjoyable and informing session where all the ‘difficult’ questions were asked and good straightforward answers were given. For us two key areas of interest, GARS and the dividend proved to be areas where we felt we could take comfort from the answers given. Having concluded that many of the perceived ‘issues’ were not material we believe that the investment case is even stronger than we had previously thought. In our view the shares are undervalued and offer significant upside potential on a 12 month view. Buy.
10 Aug 16
"There was nothing particularly significant from the overnight markets to set the opening trend for London this morning, so investors are instead likely to focus back on yesterday’s report from the National Institute for Economic and Social Research, which reported that the UK economy shrunk by 0.2% in the first full month following Brexit, as political tensions and concerns regarding the UK’s prospective relationship with the EU knocked confidence. This, added to the Bank of England’s reported failure to buy back as many government bonds as it had targeted during the first couple of days of its six-month, £60bn programme, highlights the fact that the process of stimulating risk markets can never be straight forward. London equities accordingly look to be setback at the opening this morning, with the FTSE- 100 seen falling up to 15 points in early trade. Overnight, the US markets saw quiet, low volume activity push all three principal indices modestly into the positive, with the tech-heavy NASDAQ leading the way and closing at a new record high. Yen strength was again the main talking point in Asia as Japan reported June core machinery orders rebounding from previous weakness; while gains of half a percent against the US$ kept the Nikkei under pressure other markets in the region ended mixed with commodity stocks amongst the main losers. This morning the UK will report CML Housing Market Data while the BoE Agents’ Summary of Business Conditions is also due for release. Half-yearly earnings are also due from Centamin (CEY.L), G4S (GFS.L), Interserve (IRV.L), Trafalgar New Homes (TRAF.L) and the Prudential (PRU.L)." - Barry Gibb, Research Analyst
Panmure Morning Note 09-08-2016
09 Aug 16
Standard Life has reported a good set of H1 figures. IFRS pre-tax Operating profit at £341m (+18%) was ahead of our in line with consensus forecast at £315m. The beat is driven largely by a one off benefit linked to the move to Solvency II. The interim dividend was at 6.47p per share (+7%) in line with our 6.48p/share forecast. Group AUA at 30 June was well ahead of expectations at £328bn (31 Dec 2015: £307.4bn) compared to our £320m forecast reflecting market movements towards the period end and positive FX post Brexit. The shares are trading on 2016/17F PE multiples of 11.7x and 10.8x respectively together with a 2016F dividend yield of 6.2% which view as a Buying opportunity.
H1 2016 Results preview
03 Aug 16
Standard Life will report its H1 20165 Results on Tuesday 9th August (same day as L&G) at a slightly earlier time of 6.30am. We are anticipating good underlying performance on a continuing basis with Operating Profit at £315m (+9%) and an interim dividend of 6.48p per share (+7.6%). Trading on 2016/17F PE multiples of only 11.0x and 10.1x respectively and yet delivering a 2016F dividend yield of 6.6%, we view the valuation as a buying opportunity and reiterate our 433p/share target price. Buy, target price 433p.
Elevating Standard Life to a new platform
04 May 16
Standard Life has announced that it is to acquire the “Elevate” platform for financial advisers from AXA UK. It adds 160k customers and £9.8bn of AUA. No price is given but we understand that the price is a fraction of the £250m that has been rumoured in the trade press. We also understand that the platform will not be merged with the Standard Life wrap platform but that they will be run alongside each other with the potential to make some savings from the common technology provider. We view the acquisition as a good opportunistic move that increases the market share to c15% of the total assets on platforms in the UK.
Panmure Morning Note 20-04-2016
20 Apr 16
The announcement last night that Standard Life’s Indian JV “HDFC Standard Life” is to IPO is not new news but in our view it should lead to a realistic valuation being placed on its 26% shareholding. As previously announced its 26% stake is in the process of being increased to 35% rather than the potential 49% to help liquidity ahead of the float. The price being paid to increase its stake to 35% implies a valuation of its entire stake at c£700m but we believe that this could increase to c£1bn at IPO. In our view this is materially higher than the current implied valuation within the share price and could lead to a bounce as/when the IPO valuation becomes clearer. We maintain our Buy recommendation and 433p target price.
Mobilising the strategy
08 Dec 16
PCF has reported a good set of FY16 figures this morning. Pro forma 12 month adjusted pre-tax profit increased 38% YoY to £4.0m (FY15: £2.9m), 5% ahead of our estimate of £3.8m. Fully diluted return on equity remained broadly stable YoY at 13% but beat our forecast of 12.6%, driven by good loan book growth, up 14% YoY to £122m. Given the strength of the results the board has reinstated a dividend of 0.1p per share. Following Tuesday’s announcement of the approval of a banking licence, we believe that the group now has the capacity to accelerate its growth prospects. While the shares trade at 12.0x earnings and 2.0x reported book value, we do not believe this valuation captures the growth potential of the business.
VPC Speciality Lending Investments PLC – sticking to your knitting pays dividends
05 Dec 16
A 25% discount on a dividend paying vehicle suggests either (a) lack of belief in the NAV, (b) lack of belief in the dividend, (c) concerns over future delivery, (d) a shareholder’s base not normally exposure to “closed end structures” or (e) some combination of (a) to (d). We had a first meeting with the management team and London representative of VPC Speciality Lending to try to better understand why the share price had fallen quite so much.
Small Cap Breakfast
07 Dec 16
Creo Medical group—Schedule 1 update.. £20m raise. Expected market cap £61.2m, admission expected 9 December. ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.8m. Target date 14 Dec. Expected market cap £15m. RM Secured Direct Lending - The secured direct lending fund intends to float on the Main Market on 15 December raising up to £100m
Better Capital – A tale of two funds
05 Dec 16
Our gut feel on the results is that BCAP’s Gardner disposal feels viable (albeit as a late Q1 transaction). Post Gardner, the exit profile for BCAP’s portfolio is slanted towards the years 2018/19 and not earlier; we view the market’s current pricing as cautious (14% disc to our estimate of FV). In contrast, BC12’s more consumer facing portfolio remains a work in progress and may well offer further disappointment before turning a corner; the market valuation (51% discount to NAV) is cautious but probably fair given the difficulties.
Panmure Morning Note 07-12-2016
07 Dec 16
PCF today announces that it has succeeded in achieving once its major strategic goals by being granted a UK banking licence. In line with prior guidance, the company aims to begin taking deposits in summer 2017 and will initially focus on lending to its core markets in consumer motor finance and SME asset finance. As well as supporting growth in the loan book, the banking licence will both diversify and reduce the cost of its funding base. More details are expected as part of the FY16 results tomorrow.
Meeting near-term headwinds
06 Dec 16
In its trading update IFG reported that performance has been in line with management expectations. The cooling effect of market uncertainty on growth in James Hay and financial advice client numbers, together with the impact of low interest rates, remain a near-term head wind for revenues. Even so, with Saunderson House continuing to increase profits, IFG expects to match 2015 earnings. The long-term growth opportunity presented by an ageing population and pension freedoms remains in place and to address this IFG is continuing investment to enhance its service and increase operational gearing.